Synapse - Hematologic Malignancies, Division of

Search Within

Hematologic Malignancies, Division of

Results (13379)

Early adjuvant treatment after risk-adapted autologous stem cell transplant for systemic light-chain amyloidosis: Increased hospitalizations and impaired immune recovery but improved responses and overall survival

Meeting Abstract

Hoffman, J. E.; Hassoun, H.; Landau, H.; Hoover, E.; Cohen, A.; Nimer, S.; Comenzo, R.
Blood (2008)

Fulltext@MSK | Save

IL-15 augments in-vitro expansion and functional activity of antigen-specific effector memory T-cells (T(EM)) while co-expression of IL-15 and IL-15 R alpha on antigen presenting cells also promotes expansion of central memory T-cells (T(CM))

Meeting Abstract

Hasan, A.; Selvakumar, A.; Dupont, B.; Sadelain, M.; Riviere, I.; O'Reilly, R. J.
Blood (2008)

Fulltext@MSK | Save

Sequential RCHOP and yttrium-90 ibritumomab tiuxetan (RIT) is a highly effective regimen for high risk elderly patients with untreated DLBCL

Meeting Abstract

Hamlin, P. A.; Moskowitz, C. H.; Wegner, B.; Noy, A.; Gerecitano, J.; Palomba, M. L.; Portlock, C.; Straus, D.; Pro, B.; Fayad, L.; more...
Annals of Oncology (2008)

Fulltext@MSK | Save

Elevations in creatine kinase occur frequently in patients treated with imatinib mesylate (Gleevec)

Meeting Abstract

Gordon, J. K.; Magid, S. K.; Berman, E.
Arthritis and Rheumatism (2008)

Fulltext@MSK | Save

Bortezomib (Bor) with rituximab (R), cyclophosphamide (C) and prednisone (P): Two dosing schedules of a novel phase I regimen in patients with relapsed/refractory indolent and mantle cell lymphomas

Meeting Abstract

Gerecitano, J.; Portlock, C.; Hamlin, P.; Moskowitz, C.; Noy, A.; Straus, D.; Zelenetz, A. D.; Schulman, P.; Dumitrescu, O.; O'Connor, O. A.
Annals of Oncology (2008)

Fulltext@MSK | Save

A phase I/II trial of the kinesin spindle protein (KSP) inhibitor SB-743921 administered on days I and 15 every 28 days without and with prophylactic G-CSF in non-Hodgkin or Hodgkin lymphoma

Meeting Abstract

Gerecitano, J.; O'connor, O.; Van Deventer, H.; Hainsworth, J.; Leonard, J.; Goy, A.; Afanasyev, B.; Chen, M.; Saikali, K.; Conlan, M. G.; more...
Blood (2008)

Fulltext@MSK | Save

A placebo-controlled phase III trial of patient-specific immunotherapy with mitumprotimut-T (ID-KLH) and GM-CSF following rituximab in patients with CD20+ follicular lymphoma

Meeting Abstract

Freedman, A. S.; Neelapu, S.; Nichols, C. R.; Robertson, M.; Djulbegovic, B.; Winter, J. N.; Gold, D.; Bender, J.; Stewart, M.; Ghalie, R. G.; more...
Blood (2008)

Fulltext@MSK | Save

Small molecule inhibition of Cdc7, a key cell cycle regulator and novel therapeutic target, successfully inhibits leukemia cell growth in vitro and in vivo

Meeting Abstract

Frattini, M. G.; Shum, D.; O'dwyer, K. M.; Brentjens, R. J.; Yeh, R.; Maslak, P.; Heaney, M. L.; Jurcic, J.; Djaballah, H.; Kelly, T. J.
Blood (2008)

Fulltext@MSK | Save

Graft-vs-graft immune interaction is the likely mechanism of absolute unit dominance in double unit cord blood (DCB) transplantation using patient DCB grafts: An in vivo but not in vitro phenomenon

Meeting Abstract

Eldjerou, L. K.; Chaudhury, S.; He, M.; Arcila, M. E.; Salazar, P. A.; O'Reilly, R. J.; Barker, J. N.; Moore, M. A. S.
Blood (2008)

Fulltext@MSK | Save

Dasatinib is associated with durable treatment responses in chronic phase chronic myeloid leukemia: Long-term follow-up from the phase I trial (Ca180002)

Meeting Abstract

Cortes, J.; Sawyers, C. L.; Kantarjian, H. M.; Shah, N. P.; Paquette, R.; Bleickardt, E.; Paliwal, P.; Talpaz, M.
Haematologica (2008)

Fulltext@MSK | Save